Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05364424
Title A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant Eligible Diffuse B-Cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center UCI ACTIVE_NOT_RECRUITING Orange California 92868 United States Details
Memorial Cancer Institute at Memorial West ACTIVE_NOT_RECRUITING Pembroke Pines Florida 33028 United States Details
The University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Tulane Medical Center; Investigational/Research Pharmacy ACTIVE_NOT_RECRUITING New Orleans Louisiana 70112 United States Details
UMASS Memorial Medical Center RECRUITING Worcester Massachusetts 01655 United States Details
New York University Langone Medical Center RECRUITING New York New York 10016 United States Details
Cleveland Clinic Foundation; Cleveland Clinic Cancer Center/I40 ACTIVE_NOT_RECRUITING Cleveland Ohio 44195 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field